Tablet production for preclinical and clinical use demands a coordinated scientific and manufacturing strategy to ensure consistent quality, patient safety, and regulatory compliance. Our cross-functional teams—including formulation scientists, quality professionals, regulatory specialists, clinicians, and manufacturing experts—collaborate throughout every stage of development to deliver robust tablet formulations.
By applying advanced analytical tools and modern production technologies, we maintain strict oversight from incoming material qualification through final product release. Each tablet is manufactured under controlled conditions to meet global pharmaceutical standards for safety, performance, and reliability.
Connect with our experts to discuss your tablet manufacturing requirements.
Within our Manufacturing Practice–compliant facility, we support the development and manufacture of oral solid dosage forms for both preclinical and clinical trials. Tablets remain one of the most widely used and patient-preferred dosage forms, offering convenience, accurate dosing, and scalable production.
Our manufacturing process converts active pharmaceutical ingredients and excipients into high-quality solid dosage forms using advanced equipment designed to improve process control and product consistency. We support production from early development batches through commercial-scale manufacturing.
Our flexible manufacturing approaches are tailored to your formulation and regulatory needs, ensuring each tablet delivers consistent therapeutic performance while meeting applicable compliance standards.
We continuously integrate emerging manufacturing innovations to enhance efficiency, reduce costs, and shorten development timelines. Our end-to-end tablet manufacturing capabilities support seamless progression from formulation development to large-scale commercial production—helping advance your most promising drug candidates with confidence.